Caroline Pearson testified before the United States Senate Committee on Finance on the importance of improved healthcare data transparency.

Her testimony summarized key findings from the Center’s work and other research on how transparency can shape healthcare markets. It also puts forth a range of policy options that Congress and the Executive Branch should consider to further advance discrete elements of healthcare data transparency, with an emphasis on how to improve the depth, breadth and usability of pricing data.